Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 16.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,200 shares of the biotechnology company’s stock after buying an additional 1,700 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Axon Enterprise were worth $7,251,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in AXON. Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 234.5% during the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock worth $116,000 after buying an additional 204 shares during the last quarter. Ballentine Partners LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $293,000. Allworth Financial LP increased its holdings in shares of Axon Enterprise by 7.1% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the biotechnology company’s stock worth $402,000 after buying an additional 67 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Axon Enterprise by 23.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,329 shares of the biotechnology company’s stock worth $2,502,000 after buying an additional 1,196 shares during the last quarter. Finally, Forsta AP Fonden increased its holdings in Axon Enterprise by 10.9% in the 3rd quarter. Forsta AP Fonden now owns 15,300 shares of the biotechnology company’s stock valued at $6,114,000 after purchasing an additional 1,500 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is owned by insiders.

Axon Enterprise Stock Down 2.6 %

Shares of NASDAQ AXON opened at $499.73 on Tuesday. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The firm’s 50 day moving average price is $616.95 and its 200 day moving average price is $520.78. The firm has a market cap of $38.11 billion, a P/E ratio of 129.13, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.